Correlation Between Inhibrx and Harrow Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Harrow Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Harrow Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Harrow Health 8625, you can compare the effects of market volatilities on Inhibrx and Harrow Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Harrow Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Harrow Health.

Diversification Opportunities for Inhibrx and Harrow Health

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Inhibrx and Harrow is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Harrow Health 8625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health 8625 and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Harrow Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health 8625 has no effect on the direction of Inhibrx i.e., Inhibrx and Harrow Health go up and down completely randomly.

Pair Corralation between Inhibrx and Harrow Health

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Harrow Health. In addition to that, Inhibrx is 8.13 times more volatile than Harrow Health 8625. It trades about -0.03 of its total potential returns per unit of risk. Harrow Health 8625 is currently generating about 0.07 per unit of volatility. If you would invest  2,504  in Harrow Health 8625 on September 27, 2024 and sell it today you would earn a total of  34.60  from holding Harrow Health 8625 or generate 1.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Harrow Health 8625

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Harrow Health 8625 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health 8625 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Harrow Health is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Inhibrx and Harrow Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Harrow Health

The main advantage of trading using opposite Inhibrx and Harrow Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Harrow Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health will offset losses from the drop in Harrow Health's long position.
The idea behind Inhibrx and Harrow Health 8625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital